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Abstract
Background: Placenta previa and placenta accreta associate with high morbidity and mortality for both mothers
and fetus. Metal exposure may have relationships with placenta previa and placenta accreta. This study analyzed
the associations between maternal metal (cadmium [Cd], lead [Pb], mercury [Hg], selenium [Se], and manganese
[Mn]) concentrations and placenta previa and placenta accreta.
Methods: We recruited 17,414 women with singleton pregnancies. Data from a self-administered questionnaire
regarding the first trimester and medical records after delivery were analyzed. Maternal blood samples were
collected to measure metal concentrations. The subjects were classified into four quartiles (Q1, Q2, Q3, and Q4)
according to metal concentrations.
Results: The odds ratio for placenta previa was significantly higher among subjects with Q4 Cd than those with Q1
Cd. The odds ratio for placenta previa was significantly higher for subjects with Q2 Pb than those with Q1 Pb.
Conclusion: Participants with placenta previa had higher Cd concentrations. However, this study was cross-
sectional and lacked important information related to Cd concentration, such as detailed smoking habits and
sources of Cd intake. In addition, the subjects in this study comprised ordinary pregnant Japanese women, and it
was impossible to observe the relationship between a wide range of Cd exposure and placenta previa. Therefore,
epidemiological and experimental studies are warranted to verify the relationship between Cd exposure and
pregnancy abnormalities.
Keywords: Metal concentration, Placenta previa, Placenta accreta, Pregnancy
Introduction
Placenta previa is a condition in which the placenta is at-
tached to the lower uterine segment and completely or
partially covers the internal cervix [1]. When chorionic
villi abnormally invade the myometrium, placenta
accreta occurs [2]. Currently, reported rates of placenta
previa are between 0.3 and 0.8% [3, 4]. The placenta
accreta rate varies because of differences in subjects;
however, it is 0.4% in Japan [5, 6]. Placenta previa and
placenta accreta are related: 9.3% of women with pla-
centa previa have placenta accreta [2]. Both cases
present risks to the mother and fetus. For the mother,
affected pregnancies are associated with excessive hem-
orrhaging, damage to surrounding organs, and death.
The fetus may experience preterm delivery, may be small
for gestational age, or may have congenital defects [7, 8].
Successful implantation requires the following complex
mechanisms: the fertilized egg/blastocyst migrates from
the oviduct to the uterine cavity and orients in appropriate
regions of the uterus (migration); the trophoblast attaches
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to the uterine epithelium (attachment); the trophoblast at-
taches firmly to the uterine epithelium (adhesion); the
trophoblast penetrates the uterine epithelium (penetra-
tion); and the trophoblast invades the uterine endomet-
rium (invasion) [9–11]. Placenta previa and placenta
accreta share overlapping risk factors, many of which are
associated with disruption of the normal uterine endomet-
rium. These risks include previous cesarean deliveries,
manual removal of the placenta, or other gynecological
surgeries that result in scarring and are likely to lead to in-
appropriate attachment during implantation [12, 13].
Environmental exposure to smoking and air pollution
has also been reported as a risk factor for placenta previa
and placenta accreta [14, 15]. Smoking influences the
maternal immune response and inflammatory response
during pregnancy [16, 17]. Inflammation leads to female
genital tract damage, including damage to the endomet-
rial and myometrial epithelium [18]. Therefore, smoking
may induce inappropriate attachment and lead to pla-
centa previa and placenta accreta. Another important
factor during the implantation process is angiogenesis
[19, 20]. Placental vascularization has been found to be
significantly decreased in smoke-exposed placentas [21].
Cigarettes contain many harmful substances, including
heavy metals [22], and current and former smoking has
been related to high cadmium (Cd) and lead (Pb) levels
in uterus tissues [23]. Exposure to heavy metals, espe-
cially Cd and Pb, impacts the female reproductive sys-
tem [24]. Furthermore, Cd, Pb, and mercury (Hg) might
affect endometrial angiogenesis [25, 26]. However, no
studies have examined the relationship between metal
exposure and placenta previa and placenta accrete
directly.
Selenium (Se) and manganese (Mn) are essential ele-
ments which have been related to blastocyst quality and
implantation [27–29]. However, there is no research to
investigate the relationship between these metals and
placenta previa and placenta accrete.
Therefore, the purpose of this study was to examine
the relationship between metal exposure and placental
previa and placenta accreta using the Japan Environment
and Children’s Study (JECS), which is a large cohort
study.
Methods
Study subjects
During this study, our target subjects were pregnant
women participating in the JECS. They were recruited
during early pregnancy at obstetric facilities and/or local
government offices [30] in 15 regions across a wide geo-
graphical area in Japan between January 2011 and March
2014.
Of the 17,998 women whose metal concentrations
were measured, 17,414 had singleton pregnancies. After
excluding women with missing data (N = 1395), 16,019
women were selected for analysis (Fig. 1).
Questionnaires
Self-administered questionnaires were provided at pre-
natal examinations or by mail to the women twice dur-
ing pregnancy (during the first trimester [T1] and the
second/third trimester [T2]). Data from the question-
naire provided during T1 were used in this study. Med-
ical record transcription was performed by physicians,
midwives/nurses, or research coordinators after delivery
[30–32]. Data for those with and without placenta previa
and placenta accreta were obtained from medical re-
cords. The present study was based on the jecs-ag-ai-20,
160,424 data set, which was released in June 2016 and
revised in October 2016.
Blood collection
Metal concentrations were measured in T2 blood sam-
ples comprising 33 mL of blood collected from each
pregnant mother. The present study was based on the
jecs-mtl-ai-20,170,403 data set, which was released in
April 2017.
Measurements of metal concentrations in blood
We measured the metal concentrations in the blood ac-
cording to our previous report [33]. Briefly, blood sam-
ples with sodium ethylenediaminetetraacetic acid
(EDTA) were transferred to a central laboratory and
stored at − 80 °C before use. A standard solution com-
prising all target elements except Hg was prepared in
0.14M nitric acid. An Hg standard solution was pro-
duced using a solution made from 0.056M nitric acid,
0.5% w/v EDTA, and 1% v/v tetramethylammonium hy-
droxide (TMAH). The final concentrations of Hg, Pb,
Cd, Mn, and Se in the standard solution were 200, 200,
20, 600, and 2000 ng/g, respectively. An internal stand-
ard (yttrium, indium, and thallium at 250 ng/g) was pre-
pared using 0.14M nitric acid. Blood samples (200 μL)
were diluted (1:19) with the dilution solution (2% v/v
butan-1-ol, 0.1% TMAH, 0.05% w/v polyoxyethlene
octylphenyl ether, and 0.05% w/v H4EDTA) [10] and
vortex-mixed before the inductively coupled plasma
mass spectrometry (ICP-MS) analysis.
ICP-MS measurements of metals in the blood were
performed using Agilent 7700 ICP-MS (Agilent Tech-
nologies, Tokyo, Japan). Method detection limits for
each analyte were calculated according to the method
described previously [34]. The intensity of Pb isotypes
was the summation of that of 206Pb, 207Pb, and 208Pb. To
correct the spectral overlap from molybdenum oxide
(95Mo16O), the intensity of 111Cd was calculated using
the following equation:
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Cd½  ¼ m=z 111 intensity½   m=z 95 intensity½ 
 95Mo16O generation rate½ 
The 95Mo16O generation rate was derived from the
following equation:
95Mo16O generation rate½  ¼ ½the intensity of m=z 111 when 100
ppb 95Mo standard solution was analyzed=½the intensity of m=z
96 when 100ppb 95Mo standard solution was analyzed
Statistical methods
Two-group comparisons were performed using the
Mann-Whitney U test and multivariable logistic regres-
sion analyses. The p values of the multivariable logistic
regression analysis were calculated after adjusting for
age, smoking, smoking habits of the partner, drinking
habits, gravidity, parity, number of cesarean deliveries,
and geographic region [35, 36]. Placenta previa was
added as a covariate when comparisons were performed
with or without placenta accreta. Subjects were divided
equally into quartiles depending on individual metal
concentrations (first quartile [Q1], second quartile [Q2],
third quartile [Q3], fourth quartile [Q4]); these quartiles
were used in the multivariable logistic regression analysis
and trend test.
All analyses were performed using Stata version 14
(Stata Corp., College Station, TX, USA), and statistical
significance was assumed when p < 0.05 (two-sided).
Results
Table 1 shows characteristics of the study population.
The rates of placenta previa and placenta accreta were
0.5% and 0.2%, respectively, among subjects. Four
women had placenta previa and placenta accreta.
Table 2 shows the distribution of metal concentra-
tions by smoking habits. Cd and Pb concentrations of
current smokers were high in our study (Cd; p <
0.001, Pb; p < 0.001 by analysis of variance [ANOVA]).
In contrast, Hg and Mn concentrations of current
smokers were low in our study (Hg; p < 0.001, Mn;
p < 0.001 by ANOVA).
Figure 2 shows the relationship between metal concen-
trations and placenta previa. There was a significant dif-
ference in Cd concentrations for the two placenta previa
groups (median [ng/g]: without, 0.66; with, 0.79; P =
0.004). There were no significant differences between
other metals and placenta previa.
Fig. 1 Flow chart of the study subjects. Of the samples collected from the 97,979 women during mid to late pregnancy, 20,000 whole blood
samples were randomly selected. To measure metal concentrations, 17,998 blood samples of women who met the QC criteria were used. Of
these 17,998, 17,414 who delivered singleton pregnancies were selected. After excluding women with missing data (N = 1395), the final study
population comprised of 16,019 women. Cd, cadmium; Pb, lead; Hg, mercury; Se, selenium; Mn, manganese; QC, quality control
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Figure 3 shows the relationship between metal concen-
trations and placenta accreta. There were no significant
differences between all metals and placenta accreta.
To further assess the association between levels of metal
concentrations and placenta previa and placenta accreta, we
performed multivariable logistic regression analyses by using
the quartile variables of metal concentrations. The odds ra-
tio (OR) for placenta previa was significantly higher among
subjects with Q4 Cd than those with Q1 Cd (OR, 2.06; 95%
confidence interval [CI], 1.07, 3.98; p= 0.031). Further, the
OR for placenta previa was significantly higher among sub-
jects with Q2 Pb than those with Q1 Pb (OR, 2.59; 95% CI,
1.40, 4.80; p= 0.003). There was a significant relationship be-
tween placenta previa and Pb concentrations (P for trend =
0.007). There was no significant relationship between pla-
centa accreta and metal concentrations (Table 3).
Table 1 Study population characteristics
Total (N =
16,019)
Previa Accreta
Without (N = 15,929) With (N = 90) p value† Without (N = 15,980) With (N = 39) P value†
Age (years) 31.3 ± 5.0 31.3 ± 5.0 32.9 ± 4.7 0.003 31.3 ± 5.0 34.1 ± 5.2 0.002
Smoking habits
Never 9194 (57) 9136 (57) 58 (64) 9173 (57) 21 (54)
Former 6002 (37) 5974 (38) 28 (31) 0.224 5989 (37) 13 (33) 1.000
Current 823 (5) 819 (5) 4 (4) 0.817 818 (5) 5 (13) 0.057
Smoking habits of partner
Never 4281 (27) 4251 (27) 30 (33) 4265 (27) 16 (41)
Former 4339 (27) 4314 (27) 25 (28) 0.501 4326 (27) 13 (33) 0.582
Current 7399 (46) 7364 (46) 35 (39) 0.122 7389 (46) 10 (26) 0.013
Drinking habits
No 14,386 (90) 14,307 (90) 79 (88) 14,355 (90) 31 (79)
Yes 1633 (10) 1622 (10) 11 (12) 0.485 1625 (10) 8 (21) 0.055
Gravidity
Primigravida 4758 (30) 4733 (30) 25 (28) 4751 (30) 7 (18)
Multigravida 11,261 (70) 11,196 (70) 65 (72) 0.730 11,229 (70) 32 (82) 0.117
Parity
Nulliparous 6385 (40) 6348 (40) 37 (41) 6372 (40) 13 (33)
Multiparous 9634 (60) 9581 (60) 53 (59) 0.829 9608 (60) 26 (67) 0.513
Number of cesarean deliveries
0 14,576 (91) 14,496 (91) 80 (89) 14,542 (91) 34 (87)
1 1111 (7) 1106 (7) 5 (6) 0.833 1108 (7) 3 (8) 0.744
2 305 (2) 300 (2) 5 (6) 0.030 303 (2) 2 (5) 0.168
≥ 3 27 (0) 27 (0) 0 (0) 1.000 27 (0) 0 (0) 1.000
Values are mean ± SD or number (%)
†p values for age were obtained using Welch’s t test. p values for other factors were obtained using Fisher’s exact test
Table 2 The distribution of metal concentrations by smoking habits
Median (ng/g) (25th and 75th percentiles)a p value*
Total
(N = 16,019)
Smoking habits
Never (N = 9194) Former (N = 6002) Current (N = 823)
Cd 0.66 (0.50, 0.91) 0.64 (0.48, 0.86) 0.66 (0.50, 0.90) 1.07 (0.78, 1.44) < 0.001
Pb 5.96 (4.80, 7.45) 5.81 (4.69, 7.24) 6.08 (4.93, 7.61) 6.92 (5.56, 8.74) < 0.001
Hg 3.65 (2.57, 5.16) 3.75 (2.65, 5.27) 3.53 (2.51, 5.00) 3.40 (2.35, 5.02) < 0.001
Se 169 (158, 183) 169 (157, 183) 170 (158, 183) 170 (158, 184) 0.339
Mn 15.3 (12.6, 18.7) 15.5 (12.8, 18.8) 15.2 (12.5, 18.6) 14.8 (12.3, 17.9) < 0.001
*p values were obtained using ANOVA
aNatural log-transformed variables were used for ANOVA
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Discussion
Two significant results were obtained during this re-
search. First, the group with placenta previa had higher
Cd concentrations than the group without placenta pre-
via. In addition, subjects with Q4 Cd were at higher OR
for placenta previa than those with Q1 Cd. Second, sub-
jects with Q2 Pb were at significantly higher OR for pla-
centa previa than those with Q1 Pb.
Cd and Pb have several exposure sources, such as food
and soil [37, 38]. Especially smoking is a major source of
Cd and Pb [39]. Other reports have described the relation-
ship between smoking and placenta previa [14, 40]. In-
deed, the Cd and Pb concentrations of smokers were high
in our study. Therefore, tobacco acts as one of the definite
sources of Cd and Pb exposure. However, we categorized
the smoking habits for the two groups—never smokers or
former/current smokers—and we performed multivariable
logistic regression analyses between metal concentrations
and placenta previa. In the group of never smokers, the
OR of placenta previa was higher among subjects with
Q2–Q4 Cd and Pb than those with Q1 (Additional file 1:
Table S1). These results show the same trend as seen in
Table 3, which involved analysis without dividing the
groups into never smokers and former/current smokers.
Therefore, the possibility that Cd and Pb are themselves
related to placenta previa cannot be discounted.
A B
C
E
D
Fig. 2 Relationships between metal concentrations in the blood and placenta previa. The relationships between metal concentrations in the
second/third trimester (T2) blood and placenta previa are shown. A box plot displays a box bordered at the 25th and 75th percentiles of the
variable on the y-axis with a median line at the 50th percentile of each metal concentration. p values were calculated using the Mann-Whitney U
test. a Relationship between Cd concentration and placenta previa. b Relationship between Pb concentration and placenta previa. c Relationship
between Hg concentration and placenta previa. d Relationship between Se concentration and placenta previa. e Relationship between Mn
concentration and placenta previa. Cd, cadmium; Pb, lead; Hg, mercury; Se, selenium; Mn, manganese
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The median Cd concentration in our study was 0.66
ng/g, which was lower than those reported previously in
Japan [41, 42] and low compared to those of residents
living in Cd-polluted areas [43]. Regarding Cd, in recent
years, it has been reported that exposure to low-dose Cd
affects the health of those in non-polluted areas and
non-smokers [44]. Therefore, further epidemiological
studies and experimental studies involving cell lines and
animals are warranted to clarify the relationship between
placenta previa and various dose Cd exposure.
The OR for placenta previa was significantly higher
among subjects with Q2 Pb than those with Q1 Pb.
Women with Q3 Pb group and Q4 Pb group did not
demonstrate a significant relationship; however, the OR
for placenta previa was higher in those in the Q1 Pb
group. It is not clear why Q2 Pb had the highest OR.
Therefore, although not in a dose-dependent manner, it
cannot be denied that Pb exposure may have some effect
on the placenta previa.
Our study has several limitations. First, the source of
exposure to Cd in this study was unknown. Smoking is
one of the sources of exposure to Cd; however, we had
no information regarding the number of cigarettes per
day or when subjects quit smoking. Therefore, we could
not accurately determine the influence of Cd exposure
attributable to smoking. In addition to smoking, there
A B
C
E
D
Fig. 3 Relationships between metal concentrations in the blood and placenta accreta. The relationships between metal concentrations in the
second/third trimester (T2) blood and placenta accreta are shown. A box plot displays a box bordered at the 25th and 75th percentiles of the
variable on the y-axis with a median line at the 50th percentile of each metal concentration. p values were calculated using the Mann-Whitney U
test. a Relationship between Cd concentration and placenta accreta. b Relationship between Pb concentration and placenta accreta. c Relationship
between Hg concentration and placenta accreta. d Relationship between Se concentration and placenta accreta. e Relationship between Mn
concentration and placenta accreta. Cd, cadmium; Pb, lead; Hg, mercury; Se, selenium; Mn, manganese
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are various other sources of Cd. Among all food sources,
rice was the most significant contributor of Cd, followed
by vegetables, seaweed, seafood, and millet [45]. There-
fore, Cd is absorbed into the human body via these
foods. The food intake of some individuals in Japan is
regionally dependent. For example, residents in the area
along the sea coast have a tendency to eat more seafood,
such as shellfish, squid, and crab, which contain much
Cd [46, 47]. Therefore, it is necessary to investigate the
relationships between the source of Cd exposure, intake
amount, blood concentrations, and placenta previa, and
to consider the regional characteristics of the food con-
sumed. Second, this study only investigated the relation-
ship between placenta previa and low-dose Cd exposure.
We could not clarify which dose of Cd (low or high) had
the most influence on placenta previa. Therefore, in the
future, it will be important to compare high Cd-polluted
areas and low-Cd-polluted areas and high Cd intake
Table 3 Results of multivariable analysis regarding the relationship between quartile concentrations of metals, placenta previa, and
placenta accreta
Quartile
concentration of
metals (ng/g)
Previa Accreta
Without (N = 15,929) With (N = 90) OR (95% CI) p value* Without (N = 15,980) With (N = 39) OR (95% CI) p value **
Cd
Q1 (≤ 0.496) 3967 14 1.00 (referent) 3971 10 1.00 (referent)
Q2 (0.497–0.661) 3999 20 1.37 (0.69–2.72) 0.375 4012 7 0.55 (0.21–1.46) 0.234
Q3 (0.662–0.904) 3982 25 1.67 (0.86–3.26) 0.129 3993 14 1.01 (0.44–2.33) 0.981
Q4 (≥ 0.905) 3981 31 2.06 (1.07–3.98) 0.031 4004 8 0.46 (0.17–1.22) 0.120
P for trend = 0.146 P for trend = 0.205
Pb
Q1 (≤4.79) 3969 14 1.00 (referent) 3976 7 1.00 (referent)
Q2 (4.80–5.95) 3987 37 2.59 (1.40–4.80) 0.003 4012 12 1.46 (0.57–3.76) 0.429
Q3 (5.96–7.44) 3975 19 1.32 (0.66–2.64) 0.436 3981 13 1.68 (0.66–4.24) 0.276
Q4 (≥ 7.45) 3998 20 1.34 (0.67–2.67) 0.411 4011 7 0.79 (0.27–2.30) 0.667
P for trend = 0.007 P for trend = 0.345
Hg
Q1 (≤ 2.56) 3948 20 1.00 (referent) 3959 9 1.00 (referent)
Q2 (2.57–3.64) 3987 29 1.37 (0.78–2.44) 0.276 4003 13 1.31 (0.55–3.08) 0.540
Q3 (3.65–5.15) 4004 19 0.89 (0.47–1.67) 0.708 4012 11 1.18 (0.48–2.86) 0.721
Q4 (≥ 5.16) 3990 22 1.03 (0.56–1.90) 0.924 4006 6 0.63 (0.22–1.77) 0.378
P for trend = 0.477 P for trend = 0.458
Se
Q1 (≤ 157) 3961 27 1.00 (referent) 3978 10 1.00 (referent)
Q2 (158–168) 3687 21 0.84 (0.47–1.49) 0.544 3700 8 0.86 (0.34–2.20) 0.756
Q3 (169–182) 4197 21 0.73 (0.41–1.30) 0.284 4209 9 0.83 (0.34–2.07) 0.695
Q4 (≥ 183) 4084 21 0.75 (0.42–1.33) 0.320 4093 12 1.13 (0.48–2.63) 0.784
P for trend = 0.693 P for trend = 0.901
Mn
Q1 (≤ 12.5) 3858 21 1.00 (referent) 3871 8 1.00 (referent)
Q2 (12.6–15.2) 3961 22 1.05 (0.58–1.91) 0.877 3966 17 2.11 (0.91–4.92) 0.083
Q3 (15.3–18.6) 4100 23 1.06 (0.58–1.92) 0.853 4116 7 0.82 (0.31–2.29) 0.710
Q4 (≥ 18.7) 4010 24 1.14 (0.63–2.06) 0.656 4027 7 0.85 (0.31–2.37) 0.758
P for trend = 0.977 P for trend = 0.080
*p values were obtained from the multivariable logistic regression analysis adjusted for age, smoking, smoking habits of the partner, drinking habits, gravidity,
parity, number of cesarean deliveries, and geographic region
**p values were obtained from the multivariable logistic regression analysis adjusted for age, smoking, smoking habits of the partner, drinking habits, gravidity,
parity, number of cesarean deliveries, placenta previa, and geographic region
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groups and low-Cd intake groups. Additional experi-
ments are needed to uncover direct relationships be-
tween Cd and placenta previa and/or the mechanism by
which Cd can affect placental formation and develop-
ment. Third, metal concentrations in the placental tissue
were not measured in the JECS study. In the future,
studies should aim to measure the concentrations of the
metal in the placental tissue and to investigate the rela-
tionship between these concentrations and placental ab-
normalities. These studies should help clarify the
relationship between metal exposure and placental ab-
normalities. Fourth, this study was a cross-sectional
study using JECS data. Therefore, the causal relationship
between Cd exposure and placenta previa could not be
considered using only this study. Iron deficiency during
pregnancy leads to increased Cd absorption and bur-
den on the body [48]. However, it is unknown
whether the increase in Cd absorption caused by iron
deficiency affects the onset of placenta previa. To
clarify the causal relationship between iron deficiency,
Cd absorption, and placenta previa, it is necessary to
measure Cd, iron, and ferritin concentrations in the
blood throughout pregnancy, especially during the
first trimester, which is an important time for normal
implantation and placentation [3]. Dietary habits and
nutritional status during pregnancy may be related to
pregnancy abnormalities [49, 50]; therefore, it is also
important to monitor the diet during pregnancy. Fur-
thermore, the JECS study was a cohort study; there-
fore, it is important to link the relationship between
maternal metal exposure, pregnancy abnormalities,
and children’s health in the future.
Conclusion
The group with placenta previa had higher whole blood
concentrations of Cd than did the group without pla-
centa previa. However, this study was cross-sectional
and did not aim at Cd exposure and its health effects
specifically, resulting in a lack of important information
regarding Cd concentration, such as detailed smoking
habits and sources of Cd intake. In addition, this study
was conducted on ordinary Japanese pregnant women,
and it was impossible to observe the relationship be-
tween a wide range of Cd exposure and placenta previa.
Placenta previa involves the risk of excessive hemorrha-
ging, damage to surrounding organs, and death for the
mother. In addition, it can cause preterm birth, small for
the gestational age status for the fetus, and congenital
defects in the fetus. To prevent placenta previa, maintain
the mother’s health, and protect the health of the fetus,
epidemiological and experimental studies are warranted
to verify the relationship between Cd exposure and preg-
nancy abnormalities.
Additional file
Additional file 1: Table S1. Results of multivariable analysis for
determining the relationship between quartile concentrations of metals
and placenta previa in never smokers and former/current smokers.
(DOCX 26 kb)
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